Sunovion has announced positive results from the Phase III clinical trial program for SUN-101 (glycopyrrolate), a nebulized long-acting muscarinic antagonist...
• Treatment of vaginal oestrogen deficiency symptoms: • Treatment of symptoms of vaginal atrophy due to oestrogen deficiency in postmenopausal women. • As pre-surgery therapy for vaginal operations and during subsequent convalescence.